Next-Generation Sequencing Market worth $29.53 billion by 2030 | MarketsandMarkets

DELRAY BEACH, Fla., Jan. 22, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Next-Generation Sequencing Market is projected to grow from about USD 14.94 billion in 2025 to USD 29.53 billion by 2030, at a CAGR of 14.6%.

Browse 1,100 market data tables and 65 figures spread through 720 pages and in-depth TOC on "NGS market- Global Forecast to 2030"

Next-Generation Sequencing Market Size & Forecast:

• Market Size Available for Years: 2024–2030
• 2025 Market Size: USD 14.94 billion
• 2030 Projected Market Size: USD 29.53 billion
• CAGR (2025–2030): 14.6%

Next-generation Sequencing Market Trends & Insights:

• The next-generation sequencing market services segment is expected to register the highest CAGR of 18.2%.
• In the next-generation sequencing market, by technology, the sequencing by synthesis segment will grow at a CAGR of 9.2%.
• In the next-generation sequencing market, by application, the diagnostics segment is projected to grow at the fastest rate (13.9%) from 2025 to 2030.
• The North American next-generation sequencing market accounted for a 41.8% revenue share in 2024.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=546 

The main factors behind the expansion of this market are increased government funding for sequencing projects, rising applications of NGS in chronic disorders, and growing applications of NGS in clinical diagnostics.

Steady advances in bioinformatics and data analytics are key drivers of the NGS market's growth. These tools facilitate the processing of sequencing data and the extraction of valuable insights. Concurrently, a broader range of applications is becoming accessible as sequencing costs decline. Personalized medicine and genome research are also gaining momentum, driven by growing government funding and initiatives. Demand for sequencing solutions is rising as population genomics and large-scale sequencing initiatives provide deeper insights into genetic diversity and disease risk. Additionally, AI- and ML-enabled workflows are increasing efficiency and accuracy, accelerating innovation.